English

PATHOGENESIS CORP

EDGAR

Quarterly report (10-Q) · filed 2000-08-14

20 filing records in this dataset, filed from 1996-05-15 to 2000-08-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

20.4 million USD

2000-06-30 · USD

Exact inputs and evidence

Revenue: 20388145 USD Source

Operating margin

-5.9%

2000-06-30 · %

Exact inputs and evidence

Operating Income: -1201998 USD Source
Revenue: 20388145 USD Source

Operating cash flow

2.52 million USD

2000-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -426676 USD Source
Operating Cash Flow: -2951544 USD Source

Free cash flow

1.52 million USD

2000-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -426676 USD Source
Operating Cash Flow: -2951544 USD Source
Capital Expenditure: 1692916 USD Source
Capital Expenditure: 692707 USD Source

Cash and cash equivalents: 4.61 million USD 2000-06-30 Source
Exact value

4605575 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

76.2 million USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Revenue: 16461342 USD · 1999-07-01 – 1999-09-30 Source
Revenue: 60844225 USD · 1999-01-01 – 1999-12-31 Source
Revenue: 41022789 USD · 1999-01-01 – 1999-09-30 Source
Revenue: 19548431 USD · 2000-01-01 – 2000-03-31 Source
Revenue: 20388145 USD · 2000-04-01 – 2000-06-30 Source

Net income

-2.07 million USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Net income: -783105 USD · 1999-07-01 – 1999-09-30 Source
Net income: -8195418 USD · 1999-01-01 – 1999-12-31 Source
Net income: -8020368 USD · 1999-01-01 – 1999-09-30 Source
Net income: -368341 USD · 2000-01-01 – 2000-03-31 Source
Net income: -742423 USD · 2000-04-01 – 2000-06-30 Source

Operating cash flow

4.79 million USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Operating cash flow: -6108811 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -6459528 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: -1239469 USD · 1999-01-01 – 1999-12-31 Source
Operating cash flow: -6108811 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -2951544 USD · 2000-01-01 – 2000-03-31 Source
Operating cash flow: -426676 USD · 2000-01-01 – 2000-06-30 Source
Operating cash flow: -2951544 USD · 2000-01-01 – 2000-03-31 Source

Capital expenditure

3.91 million USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Capital expenditure: 3044090 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 2171234 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 4385659 USD · 1999-01-01 – 1999-12-31 Source
Capital expenditure: 3044090 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 692707 USD · 2000-01-01 – 2000-03-31 Source
Capital expenditure: 1692916 USD · 2000-01-01 – 2000-06-30 Source
Capital expenditure: 692707 USD · 2000-01-01 – 2000-03-31 Source

Free cash flow

886 thousand USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Operating cash flow: -6108811 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -6459528 USD · 1999-01-01 – 1999-06-30 Source
Operating cash flow: -1239469 USD · 1999-01-01 – 1999-12-31 Source
Operating cash flow: -6108811 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -2951544 USD · 2000-01-01 – 2000-03-31 Source
Operating cash flow: -426676 USD · 2000-01-01 – 2000-06-30 Source
Operating cash flow: -2951544 USD · 2000-01-01 – 2000-03-31 Source
Capital expenditure: 3044090 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 2171234 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 4385659 USD · 1999-01-01 – 1999-12-31 Source
Capital expenditure: 3044090 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 692707 USD · 2000-01-01 – 2000-03-31 Source
Capital expenditure: 1692916 USD · 2000-01-01 – 2000-06-30 Source
Capital expenditure: 692707 USD · 2000-01-01 – 2000-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2000-08-14.

Financial data available through: 1999-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 1999-12-31
Operating income: 6 of 11 periods available· newest 1999-12-31
Net income: 6 of 11 periods available· newest 1999-12-31
Operating cash flow: 6 of 11 periods available· newest 1999-12-31
Capital expenditure: 6 of 11 periods available· newest 1999-12-31
Total assets: 4 of 11 periods available· newest 1999-12-31
liabilities: No compatible figures in this window
Current assets: 4 of 11 periods available· newest 1999-12-31
Current liabilities: 4 of 11 periods available· newest 1999-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 1999-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-0.3%

Prior period

USD 61.05 million

1998-01-01 – 1998-12-31
Current period

USD 60.84 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

60844225 − 61051764 = -207539 USD

61051764 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
60844225 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PATHOGENESIS CORP · 1999-12-31 PATHOGENESIS CORP (edgar:1001186) Year-over-year change in Revenue: -207539 USD Concept: fundies:Revenue Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 60844225 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1703 Input fundies:Revenue: 61051764 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1703
The citation records this snapshot. The page link may show a newer release later.
Net income
-535.3%

Prior period

USD 1.88 million

1998-01-01 – 1998-12-31
Current period

−USD 8.2 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

-8195418 − 1882901 = -10078319 USD

1882901 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
-8195418 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PATHOGENESIS CORP · 1999-12-31 PATHOGENESIS CORP (edgar:1001186) Year-over-year change in Net income: -10078319 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -8195418 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1833 Input fundies:NetIncome: 1882901 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1833
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 8.4 million

Prior period

−USD 9.64 million

1998-01-01 – 1998-12-31
Current period

−USD 1.24 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

-1239469 − -9635113 = 8395644 USD

-9635113 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
-1239469 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PATHOGENESIS CORP · 1999-12-31 PATHOGENESIS CORP (edgar:1001186) Year-over-year change in Operating cash flow: 8395644 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1239469 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1855 Input fundies:OperatingCashFlow: -9635113 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1855
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-58.6%

Prior period

USD 10.59 million

1998-01-01 – 1998-12-31
Current period

USD 4.39 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

4385659 − 10594811 = -6209152 USD

10594811 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
4385659 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PATHOGENESIS CORP · 1999-12-31 PATHOGENESIS CORP (edgar:1001186) Year-over-year change in Capital expenditure: -6209152 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 4385659 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1860 Input fundies:CapitalExpenditure: 10594811 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1860
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1999 1999-01-01 – 1999-12-31

Revenue USD 60.84 million 100% of revenue
Operating costs Derived USD 70.8 million 116% of revenue
Operating income −USD 9.96 million −16% of revenue
Tax, interest and other Derived −USD 1.76 million −2.9% of revenue
Net income −USD 8.2 million −13% of revenue

Cash

Operating cash flow −USD 1.24 million −2% of revenue
Capital expenditure USD 4.39 million 7.2% of revenue
Free cash flow Derived −USD 5.63 million −9.2% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1996 Operating loss: operating costs were 5,664% of revenue.
1997 Operating loss: operating costs were 8,735% of revenue.
1998 Operating loss: operating costs were 103% of revenue.
1999 Operating loss: operating costs were 116% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1996 1996-01-01 – 1996-12-31	439880	24914388 Derived	-24474508	-3210278 Derived	-21264230	-21196791 Derived	Source 1996-01-01 – 1996-12-31: 439880 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -24474508 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -21264230 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -20235007 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 961784 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	441880	38599810 Derived	-38157930	-5120200 Derived	-33037730	-36970969 Derived	Source 1997-01-01 – 1997-12-31: 441880 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -38157930 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -33037730 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -32600767 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 4370202 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	61051764	62621663 Derived	-1569899	-3452800 Derived	1882901	-20229924 Derived	Source 1998-01-01 – 1998-12-31: 61051764 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -1569899 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: 1882901 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -9635113 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 10594811 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	60844225	70801299 Derived	-9957074	-1761656 Derived	-8195418	-5625128 Derived	Source 1999-01-01 – 1999-12-31: 60844225 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -9957074 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -8195418 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -1239469 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 4385659 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 60.8M 1999

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Revenue	439880	Revenue: 439880 Open source
19971997-12-31	Revenue	441880	Revenue: 441880 Open source
19981998-12-31	Revenue	61051764	Revenue: 61051764 Open source
19991999-12-31	Revenue	60844225	Revenue: 60844225 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-0.3% 1999

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Year over year	No prior comparable period	Revenue: 439880 Open source
19971997-12-31	Year over year	0.5%	Revenue: 441880 Open source Revenue: 439880 Open source
19981998-12-31	Year over year	13,716.4%	Revenue: 61051764 Open source Revenue: 441880 Open source
19991999-12-31	Year over year	-0.3%	Revenue: 60844225 Open source Revenue: 61051764 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -16.4% 1999

Net margin -13.5% 1999

Free cash flow margin -9.2% 1999

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Operating margin	-5,563.9%	Operating Income: -24474508 Open source Revenue: 439880 Open source
19971997-12-31	Operating margin	-8,635.4%	Operating Income: -38157930 Open source Revenue: 441880 Open source
19981998-12-31	Operating margin	-2.6%	Operating Income: -1569899 Open source Revenue: 61051764 Open source
19991999-12-31	Operating margin	-16.4%	Operating Income: -9957074 Open source Revenue: 60844225 Open source
19961996-12-31	Net margin	-4,834.1%	Net Income: -21264230 Open source Revenue: 439880 Open source
19971997-12-31	Net margin	-7,476.6%	Net Income: -33037730 Open source Revenue: 441880 Open source
19981998-12-31	Net margin	3.1%	Net Income: 1882901 Open source Revenue: 61051764 Open source
19991999-12-31	Net margin	-13.5%	Net Income: -8195418 Open source Revenue: 60844225 Open source
19961996-12-31	Free cash flow margin	-4,818.8%	Revenue: 439880 Open source Operating Cash Flow: -20235007 Open source Capital Expenditure: 961784 Open source
19971997-12-31	Free cash flow margin	-8,366.7%	Revenue: 441880 Open source Operating Cash Flow: -32600767 Open source Capital Expenditure: 4370202 Open source
19981998-12-31	Free cash flow margin	-33.1%	Revenue: 61051764 Open source Operating Cash Flow: -9635113 Open source Capital Expenditure: 10594811 Open source
19991999-12-31	Free cash flow margin	-9.2%	Revenue: 60844225 Open source Operating Cash Flow: -1239469 Open source Capital Expenditure: 4385659 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.2M 1999

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Operating cash flow	-20235007	Operating Cash Flow: -20235007 Open source
19971997-12-31	Operating cash flow	-32600767	Operating Cash Flow: -32600767 Open source
19981998-12-31	Operating cash flow	-9635113	Operating Cash Flow: -9635113 Open source
19991999-12-31	Operating cash flow	-1239469	Operating Cash Flow: -1239469 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -5.6M 1999

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Free cash flow	-21196791	Operating Cash Flow: -20235007 Open source Capital Expenditure: 961784 Open source
19971997-12-31	Free cash flow	-36970969	Operating Cash Flow: -32600767 Open source Capital Expenditure: 4370202 Open source
19981998-12-31	Free cash flow	-20229924	Operating Cash Flow: -9635113 Open source Capital Expenditure: 10594811 Open source
19991999-12-31	Free cash flow	-5625128	Operating Cash Flow: -1239469 Open source Capital Expenditure: 4385659 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1996-12-31	Liabilities / assets	Not reported	Total Assets: 69998701 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 97595549 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 112765747 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 100836918 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.73× 1999

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Current assets / current liabilities	20.78×	Current Assets: 61809325 Open source Current Liabilities: 2974214 Open source
19971997-12-31	Current assets / current liabilities	10.76×	Current Assets: 87189695 Open source Current Liabilities: 8106799 Open source
19981998-12-31	Current assets / current liabilities	5.45×	Current Assets: 79784341 Open source Current Liabilities: 14630726 Open source
19991999-12-31	Current assets / current liabilities	4.73×	Current Assets: 68210739 Open source Current Liabilities: 14422462 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 14.76 million Exact value Exact value: -14762117 USD 1994-01-01 – 1994-12-31: -14762117 USD Inspect Net Income Open source Share or cite Citation for Net Income · PATHOGENESIS CORP · 1994-12-31 PATHOGENESIS CORP (edgar:1001186) Net Income: -14762117 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14762117 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001005477-97-000914.txt#2665 The citation records this snapshot. The page link may show a newer release later.	−USD 11.15 million Exact value Exact value: -11147094 USD 1994-01-01 – 1994-12-31: -11147094 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PATHOGENESIS CORP · 1994-12-31 PATHOGENESIS CORP (edgar:1001186) Operating Cash Flow: -11147094 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11147094 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001005477-97-000914.txt#2687 The citation records this snapshot. The page link may show a newer release later.	USD 1.95 million Exact value Exact value: 1953362 USD 1994-01-01 – 1994-12-31: 1953362 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PATHOGENESIS CORP · 1994-12-31 PATHOGENESIS CORP (edgar:1001186) Capital Expenditure: 1953362 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1953362 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001005477-97-000914.txt#2692 The citation records this snapshot. The page link may show a newer release later.	−USD 13.1 million Calculation and evidence -11147094 − 1953362 USD Exact free cash flow: -13100456 USD 1994-01-01 – 1994-12-31: -11147094 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 1953362 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PATHOGENESIS CORP · 1994-12-31 PATHOGENESIS CORP (edgar:1001186) Free cash flow: -13100456 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11147094 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001005477-97-000914.txt#2687 Input fundies:CapitalExpenditure: 1953362 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001005477-97-000914.txt#2692 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 18.02 million Exact value Exact value: -18023923 USD 1995-01-01 – 1995-12-31: -18023923 USD Inspect Net Income Open source Share or cite Citation for Net Income · PATHOGENESIS CORP · 1995-12-31 PATHOGENESIS CORP (edgar:1001186) Net Income: -18023923 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18023923 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0000950131-98-002176.txt#1703 The citation records this snapshot. The page link may show a newer release later.	−USD 15.34 million Exact value Exact value: -15339011 USD 1995-01-01 – 1995-12-31: -15339011 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PATHOGENESIS CORP · 1995-12-31 PATHOGENESIS CORP (edgar:1001186) Operating Cash Flow: -15339011 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15339011 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0000950131-98-002176.txt#1722 The citation records this snapshot. The page link may show a newer release later.	USD 448,350 Exact value Exact value: 448350 USD 1995-01-01 – 1995-12-31: 448350 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PATHOGENESIS CORP · 1995-12-31 PATHOGENESIS CORP (edgar:1001186) Capital Expenditure: 448350 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 448350 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0000950131-98-002176.txt#1727 The citation records this snapshot. The page link may show a newer release later.	−USD 15.79 million Calculation and evidence -15339011 − 448350 USD Exact free cash flow: -15787361 USD 1995-01-01 – 1995-12-31: -15339011 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 448350 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PATHOGENESIS CORP · 1995-12-31 PATHOGENESIS CORP (edgar:1001186) Free cash flow: -15787361 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15339011 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0000950131-98-002176.txt#1722 Input fundies:CapitalExpenditure: 448350 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0000950131-98-002176.txt#1727 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 21.26 million Exact value Exact value: -21264230 USD 1996-01-01 – 1996-12-31: -21264230 USD Inspect Net Income Open source Share or cite Citation for Net Income · PATHOGENESIS CORP · 1996-12-31 PATHOGENESIS CORP (edgar:1001186) Net Income: -21264230 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21264230 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-99-000444.txt#1832 The citation records this snapshot. The page link may show a newer release later.	−USD 20.24 million Exact value Exact value: -20235007 USD 1996-01-01 – 1996-12-31: -20235007 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PATHOGENESIS CORP · 1996-12-31 PATHOGENESIS CORP (edgar:1001186) Operating Cash Flow: -20235007 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20235007 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-99-000444.txt#1856 The citation records this snapshot. The page link may show a newer release later.	USD 961,784 Exact value Exact value: 961784 USD 1996-01-01 – 1996-12-31: 961784 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PATHOGENESIS CORP · 1996-12-31 PATHOGENESIS CORP (edgar:1001186) Capital Expenditure: 961784 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 961784 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-99-000444.txt#1862 The citation records this snapshot. The page link may show a newer release later.	−USD 21.2 million Calculation and evidence -20235007 − 961784 USD Exact free cash flow: -21196791 USD 1996-01-01 – 1996-12-31: -20235007 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 961784 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PATHOGENESIS CORP · 1996-12-31 PATHOGENESIS CORP (edgar:1001186) Free cash flow: -21196791 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20235007 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-99-000444.txt#1856 Input fundies:CapitalExpenditure: 961784 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-99-000444.txt#1862 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 33.04 million Exact value Exact value: -33037730 USD 1997-01-01 – 1997-12-31: -33037730 USD Inspect Net Income Open source Share or cite Citation for Net Income · PATHOGENESIS CORP · 1997-12-31 PATHOGENESIS CORP (edgar:1001186) Net Income: -33037730 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -33037730 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1833 The citation records this snapshot. The page link may show a newer release later.	−USD 32.6 million Exact value Exact value: -32600767 USD 1997-01-01 – 1997-12-31: -32600767 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PATHOGENESIS CORP · 1997-12-31 PATHOGENESIS CORP (edgar:1001186) Operating Cash Flow: -32600767 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32600767 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1855 The citation records this snapshot. The page link may show a newer release later.	USD 4.37 million Exact value Exact value: 4370202 USD 1997-01-01 – 1997-12-31: 4370202 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PATHOGENESIS CORP · 1997-12-31 PATHOGENESIS CORP (edgar:1001186) Capital Expenditure: 4370202 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4370202 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1860 The citation records this snapshot. The page link may show a newer release later.	−USD 36.97 million Calculation and evidence -32600767 − 4370202 USD Exact free cash flow: -36970969 USD 1997-01-01 – 1997-12-31: -32600767 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 4370202 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PATHOGENESIS CORP · 1997-12-31 PATHOGENESIS CORP (edgar:1001186) Free cash flow: -36970969 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32600767 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1855 Input fundies:CapitalExpenditure: 4370202 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1860 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	USD 1.88 million Exact value Exact value: 1882901 USD 1998-01-01 – 1998-12-31: 1882901 USD Inspect Net Income Open source Share or cite Citation for Net Income · PATHOGENESIS CORP · 1998-12-31 PATHOGENESIS CORP (edgar:1001186) Net Income: 1882901 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1882901 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1833 The citation records this snapshot. The page link may show a newer release later.	−USD 9.64 million Exact value Exact value: -9635113 USD 1998-01-01 – 1998-12-31: -9635113 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PATHOGENESIS CORP · 1998-12-31 PATHOGENESIS CORP (edgar:1001186) Operating Cash Flow: -9635113 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9635113 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1855 The citation records this snapshot. The page link may show a newer release later.	USD 10.59 million Exact value Exact value: 10594811 USD 1998-01-01 – 1998-12-31: 10594811 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PATHOGENESIS CORP · 1998-12-31 PATHOGENESIS CORP (edgar:1001186) Capital Expenditure: 10594811 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10594811 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1860 The citation records this snapshot. The page link may show a newer release later.	−USD 20.23 million Calculation and evidence -9635113 − 10594811 USD Exact free cash flow: -20229924 USD 1998-01-01 – 1998-12-31: -9635113 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 10594811 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PATHOGENESIS CORP · 1998-12-31 PATHOGENESIS CORP (edgar:1001186) Free cash flow: -20229924 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9635113 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1855 Input fundies:CapitalExpenditure: 10594811 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1860 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 8.2 million Exact value Exact value: -8195418 USD 1999-01-01 – 1999-12-31: -8195418 USD Inspect Net Income Open source Share or cite Citation for Net Income · PATHOGENESIS CORP · 1999-12-31 PATHOGENESIS CORP (edgar:1001186) Net Income: -8195418 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8195418 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1833 The citation records this snapshot. The page link may show a newer release later.	−USD 1.24 million Exact value Exact value: -1239469 USD 1999-01-01 – 1999-12-31: -1239469 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PATHOGENESIS CORP · 1999-12-31 PATHOGENESIS CORP (edgar:1001186) Operating Cash Flow: -1239469 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1239469 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1855 The citation records this snapshot. The page link may show a newer release later.	USD 4.39 million Exact value Exact value: 4385659 USD 1999-01-01 – 1999-12-31: 4385659 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PATHOGENESIS CORP · 1999-12-31 PATHOGENESIS CORP (edgar:1001186) Capital Expenditure: 4385659 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4385659 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1860 The citation records this snapshot. The page link may show a newer release later.	−USD 5.63 million Calculation and evidence -1239469 − 4385659 USD Exact free cash flow: -5625128 USD 1999-01-01 – 1999-12-31: -1239469 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 4385659 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PATHOGENESIS CORP · 1999-12-31 PATHOGENESIS CORP (edgar:1001186) Free cash flow: -5625128 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1001186?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1239469 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1855 Input fundies:CapitalExpenditure: 4385659 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1001186/0001032210-00-000633.txt#1860 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

20 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001001186, 1001186, edgar:1001186

PATHOGENESIS CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1999 1999-01-01 – 1999-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation